- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Tetracosactrin – November 2017
Tetracosactrin: Compound depot injection 1 mg in 1 mL; Synacthen® Depot 1 mg/1 mL
Last updated
2 March 2018